Pharmaceutical Studies & Trials of Individual Cannabinoids Aim to Develop Cannabis Strains That Specifically Target …

CORAL SPRINGS, Florida, July 18, 2016 /PRNewswire/ —

Medical Cannabis’ biggest strength continues to be science as research and development drives sector forward with more consumers opting for marijuana over traditional treatment methods.  Investors continue to pour millions of dollars into the newest studies and development of Medical Marijuana Applications as more states push towards legalization.

Veritas Pharma Inc. (OTC:VRTHF) (CSE:VRT) is pleased to announce a corporate update. Within the first two quarters of 2016, Veritas Pharma has managed to reach significant milestones in achieving its goals.  These milestones include formation of a uniquely qualified Board of Directors, completion of Private Placement, as well as initiating the research process and progressing towards identifying potentially new therapeutic strains of cannabis.

On April 19th, 2016, Veritas Pharma’s Board of Directors was strengthened by the appointment of Dr. Donald R. Carlow. He was the former president and CEO of the British Columbia Cancer

... read more at: http://www.prnewswire.com/news-releases/387265151.html